Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AGRX | TEVA | RDY | BBIO | BHC |
| Company | Agile Therapeutics Inc | Teva Pharmaceutical Industries ADR | Dr. Reddy's Laboratories Ltd ADR | Bridgebio Pharma Inc | Bausch Health Companies Inc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NYSE |
| Open | 0.4250 | 13.31 | 74.27 | 24.48 | 8.62 |
| High | 0.4300 | 13.98 | 74.78 | 24.99 | 8.82 |
| Low | 0.3950 | 13.31 | 74.24 | 24.32 | 8.58 |
| Last | 0.4000 | 13.81 | 74.55 | 24.88 | 8.71 |
| Change | unch | +0.56 | +0.53 | +0.55 | +0.09 |
| % Change | unch | +4.23% | +0.72% | +2.26% | +1.04% |
| Volume | 28,100 | 10,278,700 | 216,200 | 1,049,200 | 2,082,600 |
| 20-Day Average Volume | 120,470 | 8,844,905 | 182,130 | 1,559,955 | 3,936,340 |
| Previous Close | 0.4000 | 13.25 | 74.02 | 24.33 | 8.62 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3570 | 13.52 | 72.55 | 26.70 | 9.14 |
| 20-Day Raw Stochastic | 85.58% | 66.50% | 94.34% | 16.39% | 11.29% |
| 20-Day Relative Strength | 38.87% | 56.89% | 55.98% | 36.93% | 44.52% |
| Weighted Alpha | -91.80 | +67.89 | +23.18 | -7.61 | +3.29 |
| Today's Opinion | 88% Sell | 88% Buy | 88% Buy | 88% Sell | 40% Buy |
| Previous Opinion | 88% Sell | 56% Buy | 64% Buy | 88% Sell | 40% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 56% Buy | 24% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.26% since 04/19/24 | +7.39% since 04/19/24 | +4.79% since 04/19/24 | +0.57% since 04/19/24 | +0.23% since 04/19/24 |
| Low | 0.3610 on 04/24/24 | 12.69 on 04/22/24 | 70.78 on 04/24/24 | 23.68 on 04/25/24 | 8.42 on 04/22/24 |
| High | 0.4300 on 04/26/24 | 13.98 on 04/26/24 | 74.78 on 04/26/24 | 26.26 on 04/23/24 | 8.82 on 04/26/24 |
| 1-Month | |||||
| %Chg | +19.76% since 03/26/24 | -2.33% since 03/26/24 | +2.40% since 03/26/24 | -16.40% since 03/26/24 | -11.66% since 03/26/24 |
| Low | 0.2220 on 04/01/24 | 12.51 on 04/19/24 | 70.71 on 04/19/24 | 23.68 on 04/25/24 | 8.36 on 04/11/24 |
| High | 0.4300 on 04/26/24 | 14.47 on 04/08/24 | 74.78 on 04/26/24 | 31.23 on 03/27/24 | 11.46 on 04/03/24 |
| 3-Month | |||||
| %Chg | -74.68% since 01/26/24 | +15.95% since 01/26/24 | +7.20% since 01/26/24 | -30.77% since 01/26/24 | +6.48% since 01/26/24 |
| Low | 0.2000 on 03/26/24 | 11.48 on 01/30/24 | 69.23 on 01/30/24 | 23.68 on 04/25/24 | 7.68 on 02/05/24 |
| High | 1.6600 on 01/30/24 | 14.47 on 04/08/24 | 77.72 on 02/23/24 | 41.04 on 02/15/24 | 11.46 on 04/03/24 |
| 6-Month | |||||
| %Chg | -77.90% since 10/26/23 | +66.99% since 10/26/23 | +15.40% since 10/26/23 | -0.76% since 10/26/23 | +29.42% since 10/26/23 |
| Low | 0.2000 on 03/26/24 | 8.10 on 10/27/23 | 63.72 on 11/03/23 | 23.68 on 04/25/24 | 6.53 on 11/13/23 |
| High | 2.6063 on 12/04/23 | 14.47 on 04/08/24 | 77.72 on 02/23/24 | 44.32 on 12/28/23 | 11.46 on 04/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,742 | 15,482,309 | 12,440,756 | 4,374,700 | 3,182,739 |
| Shares Outstanding, K | 6,856 | 1,121,094 | 166,878 | 175,832 | 365,412 |
| Annual Sales | 19,590,000 | 15,846,000,000 | 2,992,000,000 | 9,300,000 | 8,757,000,000 |
| Annual Net Income | -14,470,000 | -559,000,000 | 548,000,000 | -643,200,000 | -592,000,000 |
| Last Quarter Sales | 3,620,000 | 4,457,000,000 | 865,780,000 | 1,750,000 | 2,408,000,000 |
| Last Quarter Net Income | -4,470,000 | 429,000,000 | 165,470,000 | -168,150,000 | -39,000,000 |
| 60-Month Beta | 1.42 | 1.05 | 0.58 | 1.03 | 0.85 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.46 on 03/28/24 | 1.00 on 01/31/24 | 0.99 on 01/31/24 | -0.96 on 02/22/24 | 1.15 on 02/22/24 |
| Latest Earnings Date | 05/09/24 | 05/08/24 | 05/07/24 | 05/02/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | 0.410 on 07/28/23 | N/A | 1.000 on 11/10/10 |
| Next Ex-Dividends Date | N/A | 11/27/17 | 07/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 5.36 | 19.53 | 0.00 | 2.46 |